Terkko Navigator / -/ Feeds / " ( ( Eteisvärinä )|( Flimmeri )|( Fibrillatio atriorum )|( Atrial fibrillation )|( Eteis"

JPM, Vol. 12, Pages 1102: Patterns and Characteristics of SKYLINE-Lumipoint Feature in the Catheter Ablation of Atypical Atrial Flutter: Insight from a Novel Lumipoint Module of Rhythmia Mapping System

Association Between Thyroid Dysfunction and Incidence of Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy

Atrial Fibrillation in Scrub Typhus: A Series of Four Cases

Elevated levels of body mass index and waist circumference, but not high variability, are associated with an increased risk of atrial fibrillation

Atrial fibrillation in low- and middle-income countries: a narrative review.

Atrial fibrillation burden, episode duration and frequency in relation to quality of life in patients with implantable cardiac monitor

Atrial fibrillation is associated with increased central blood pressure and arterial stiffness

Atrial Fibrillation Detection and Atrial Fibrillation Burden Estimation via Wearables

AF at COVID-19 Admission Predicts Mortality, Demands Vigilance

Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).

Atrial extracellular matrix remodeling in patients with atrial fibrillation.

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A COllaboration between Multiple insti

Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs

Atrial fibrillation and coronavirus infection

The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: In-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting (AFCAS) study.

The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: In-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting (AFCAS) study.

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

Atrial edema in patients with atrial fibrillation with chronic heart failure

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Emb

Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

Atrial fibrosis underlying atrial fibrillation (Review).

Atrial fibrillation and age synergistically increase clotting potential and promote atrial structural remodeling in goats

Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan　- Findings From the AF Frontier Ablation Registry.

Atrial Substrate Underlies the Recurrence after Catheter Ablation in Patients with Atrial Fibrillation.

Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation

Atrial fibrillation detection by the subcutaneous defibrillator: real-world clinical performances and implications from a multicentre study

Atrial fibrillation: villain or bystander in vascular brain injury

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study.

Different Impact of Resting Heart Rate on Adverse Events in Paroxysmal and Sustained Atrial Fibrillation　- The Fushimi AF Registry.

Atrial matrix remodeling in atrial fibrillation patients with aortic stenosis

Atrial Fibrillation Increases the Risk of Early-Onset Dementia in the General Population: Data from a Population-Based Cohort.

Atrial fibrillation as a clinical characteristic of arrhythmogenic right ventricular cardiomyopathy: Experience from the Nordic ARVC Registry.

Atrial conduction time associated predictors of recurrent atrial fibrillation

Atrial fibrillation in patients with embolic stroke of undetermined source during 3 years of prolonged monitoring with an implantable loop recorder.

Atrial fibrillation rhythm is associated with marked changes in metabolic and myofibrillar protein expression in left atrial appendage

Atrial fibrillation risk scores to evaluate left atrial substrate based on voltage analysis in long-standing persistent type of arrhythmia

Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study

Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study

Atrial endomysial fibrosis is associated with sex, atrial fibrillation, heart failure and age in cardiac surgery patients: results from the Catch-Me consortium

Atrial fibrillation and stroke risk of patients with hypertrophic cardiomyopathy in denmark from 2005-2018: a nationwide cohort study

Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: The AFCAS study.

Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: The AFCAS study.

Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study.

Atrial fibrillation after electrical cardioversion in elderly patients: a role for arterial stiffness? Results from a preliminary study.

Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.

Atrial fibrillation in patients with an atrial septal defect in a single centre cohort during a long clinical follow-up: its association with closure and outcome of therapy